Vivani Medical Inc (NAS:VANI)

$ 1.18 -0.01 (-0.84%) Market Cap: 69.90 Mil Enterprise Value: 70.52 Mil PE Ratio: 0 PB Ratio: 3.55 GF Score: 19/100

Vivani Medical Inc at ThinkEquity Conference Transcript
Oct 26, 2022
Second Sight Medical Products Inc Definitive Agreement with Nano Precision Medical Inc - M&A Call Transcript
Feb 08, 2022
Pixium Vision SA, Second Sight Medical Products, Inc. - M&A Call Transcript
Jan 06, 2021
Q4 2019 Second Sight Medical Products Inc Earnings Call Transcript
Mar 19, 2020

Earnings
Q3 2019 Second Sight Medical Products Inc Earnings Call Transcript
Nov 14, 2019

Earnings
Q2 2019 Second Sight Medical Products Inc Earnings Call Transcript
Aug 06, 2019

Earnings
Q1 2019 Second Sight Medical Products Inc Earnings Call Transcript
May 15, 2019

Earnings
Q4 2018 Second Sight Medical Products Inc Earnings Call Transcript
Mar 13, 2019

Earnings

Second Sight Medical Products Inc Definitive Agreement with Nano Precision Medical Inc - M&A Call Transcript

Feb 08, 2022 / 02:00PM GMT

Transcript

Operator

Thank you for standing by. This is the conference operator. Welcome to Second Sight investor call to discuss the company's proposed merger with Nano Precision Medical.

(Operator Instructions) The conference is being recorded. (Operator Instructions)

Speaking on today's call will be former President/CEO and current Board member of Second Sight, Will McGuire; along with Nano Precision Medical Co-founder, Chairman and CEO, Dr. Adam Mendelsohn.

Before we begin, I'd like to remind everyone that this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, along with other statements about the future expectations, beliefs, goals, plans or prospects expressed by management, constitute forward-looking statements. Any statements that are not historical fact should also be considered forward-looking statements, and forward-looking statements involve risks and uncertainties. Additional information regarding forward-looking statements can be found in the

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.